Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › Vela Diagnostics Receives EUA for Zika MDx

Vela Diagnostics Receives EUA for Zika MDx

Sep 26, 2016
|
staff reporter

A previous version of this story incorrectly stated the Vela Zika test workflow uses Qiagen's Rotor-Gene Q platform. It uses the Applied Biosystems 7500 Fast Dx Real-Time PCR platform.

NEW YORK (GenomeWeb) – A Zika assay from Singapore-based molecular diagnostics firm Vela Diagnostics has received Emergency Use Authorization from the US Food and Drug Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

What's Popular?

In PCR

  1. Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

  2. FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

  3. Centogene Reports 13 Percent Decline in Q2 Revenues

  4. Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug

  5. Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.